TLR2 and systemic sclerosis: In addition, SSc patients display increased levels of endogenous ligands of TLR2 (serum amyloid A and S100A7), TLR4 (tenascin C, fibronectin, high-mobility group protein B1 [HMGB1], and heat shock protein 90).